GSE233679 nicotinamide 5 v 1 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE233679_nicotinamide_5_v_1_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE233679_nicotinamide_5_v_1_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE233679_nicotinamide_5_v_1_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE233679_nicotinamide_5_v_1_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

small nucleolar RNA host gene 5

Gene

cytoskeleton regulator RNA

Gene

long intergenic non-protein coding RNA 1291

Gene

BAIAP2 divergent transcript

Gene

NBPF member 26

Gene

high mobility group box 1 pseudogene 5

Gene

LOXL1 antisense RNA 1

Gene

zinc finger protein 702, pseudogene

Gene

HOXA cluster antisense RNA 3

Gene

crystallin zeta like 2, pseudogene

  • Gene

    small nucleolar RNA host gene 5


  • Gene

    cytoskeleton regulator RNA


  • Gene

    long intergenic non-protein coding RNA 1291


  • Gene

    BAIAP2 divergent transcript



  • Gene

    high mobility group box 1 pseudogene 5


  • Gene

    LOXL1 antisense RNA 1


  • Gene

    zinc finger protein 702, pseudogene


  • Gene

    HOXA cluster antisense RNA 3


  • Gene

    crystallin zeta like 2, pseudogene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.